|
NSPR | Inspiremd, Inc. |
|
|
NSPR | Inspiremd, Inc. |
| Surgical & Medical Instruments & Apparatus |
| Book value per $ invested | $ 5.25 |
| Leverage | 21.13% |
| Market Cap | $ 29.3m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -51.2m |
| Margin | -437.61% |
InspireMD, Inc., a medical device company, is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of coronary and vascular disease in Europe, Latin America, the Middle East, and Asia. The company is headquartered in Tel Aviv, Israel.